Published Date: 21 Apr 2023
USA: Micro-CT (computed tomography) is a promising new tool, according to a recent study published in Annals of Surgical Oncology.
Read Full NewsOctober is Breast Cancer Awareness Month, a time to spotlight a disease that will affect hundreds of thousands of Americans this year. In the U.S., a new case of breast cancer is diagnosed about every two minutes, with more ...
Pancreatic neuroendocrine neoplasms (PNENs) are a rare form of cancer that affects hormone-producing cells in the pancreas. Although uncommon, their incidence has been rising steadily over the past few decades.
Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, targetable molecular ...
The American Cancer Society has released a report on occurrence and outcomes in the United States for this subtype of breast cancer. Findings show an estimated 33,600 women will be diagnosed with lobular breast cancer or ...
1.
Breast cancer patients' arms swell less after an effective lymph node transfer.
2.
Is Laughter Good for Blood Glucose Control?
3.
Congresswoman has cancer; the IRS is suing a controversial doctor; and caffeine and teenagers.
4.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
5.
On all CAR-T products, the FDA is calling for a new boxed warning.
1.
Optimizing the Diagnosis and Treatment of Hematological Diseases Through Artificial Intelligence
2.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
3.
The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy
4.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
5.
Immunotherapy Breakthroughs: Transforming Cancer Care Across All Oncology Fields
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
4.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation